[A bone marrow factor causing hyperglycemia and glycosuria: released glucose comes from general glycogenolysis, especially in muscle].
An agent extracted from calf bone marrow has a potent hyperglycemic effect when injected into rabbits and causes a very high glycosuric release. This high glucose release come from generalized glycogenolysis, particularly in muscles, contrary to glucagon effect. This agent has glycoprotein characteristics. It might be named, according to its origin: "erthromyelin".
D000818:Animals; D001853:Bone Marrow / Q000502:physiology*; D002417:Cattle; D005260:Female; D005916:Globulins / Q000302:isolation & purification / Q000502:physiology; D006003:Glycogen / Q000378:metabolism*; D006023:Glycoproteins / Q000502:physiology; D006029:Glycosuria; D006943:Hyperglycemia; D008099:Liver / Q000648:ultrastructure; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D008970:Molecular Weight; D009132:Muscles / Q000378:metabolism*; D011817:Rabbits; D012737:Sex Factors; D013696:Temperature
D005916:Globulins; D006023:Glycoproteins; D008112:Liver Glycogen; D006003:Glycogen
Extraction d'un facteur hyperglycémiant de la moelle osseuse rouge, provoquant une chasse glycosurique: le glucose libéré provient d'une glycogénolyse générale, notamment musculaire